Bone Marrow Failure and Myelodysplastic Syndrome Program

The Bone Marrow Failure and Myelodysplastic Syndrome (MDS) Program in the Dana-Farber/Boston Children's Cancer and Blood Disorders Center is recognized as one of the nation’s best pediatric treatment and research programs for bone marrow failure, myelodysplastic syndromes (MDS), and related conditions.

Our program has the expertise to diagnose and treat a wide range of disorders, including:

We also specialize in the evaluation of undefined bone marrow failure and MDS disorders and offer cutting edge diagnostic testing and research studies.

Find detailed information on our Bone Marrow Failure and Myelodysplastic Syndrome Program on the Dana-Farber/Boston Children's website.